HUP0204247A3 - Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity - Google Patents
Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesityInfo
- Publication number
- HUP0204247A3 HUP0204247A3 HU0204247A HUP0204247A HUP0204247A3 HU P0204247 A3 HUP0204247 A3 HU P0204247A3 HU 0204247 A HU0204247 A HU 0204247A HU P0204247 A HUP0204247 A HU P0204247A HU P0204247 A3 HUP0204247 A3 HU P0204247A3
- Authority
- HU
- Hungary
- Prior art keywords
- alkynylsubstituted
- obesity
- propionic acid
- acid derivatives
- use against
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title 1
- 229940111131 antiinflammatory and antirheumatic product propionic acid derivative Drugs 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 235000020824 obesity Nutrition 0.000 title 1
- 150000005599 propionic acid derivatives Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000137 | 2000-01-28 | ||
| DKPA200001065 | 2000-07-07 | ||
| DKPA200001593 | 2000-10-25 | ||
| PCT/DK2001/000057 WO2001055086A1 (en) | 2000-01-28 | 2001-01-26 | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0204247A2 HUP0204247A2 (hu) | 2003-04-28 |
| HUP0204247A3 true HUP0204247A3 (en) | 2003-10-28 |
Family
ID=27222337
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0204247A HUP0204247A3 (en) | 2000-01-28 | 2001-01-26 | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1254102A1 (hu) |
| JP (1) | JP2003520839A (hu) |
| KR (1) | KR20020090211A (hu) |
| CN (1) | CN1396904A (hu) |
| AU (1) | AU2831801A (hu) |
| BR (1) | BR0107902A (hu) |
| CA (1) | CA2396372A1 (hu) |
| HU (1) | HUP0204247A3 (hu) |
| IL (1) | IL150259A0 (hu) |
| MX (1) | MXPA02007295A (hu) |
| NO (1) | NO20023567L (hu) |
| PL (1) | PL357017A1 (hu) |
| WO (1) | WO2001055086A1 (hu) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI311133B (en) | 2001-04-20 | 2009-06-21 | Eisai R&D Man Co Ltd | Carboxylic acid derivativeand the salt thereof |
| JPWO2003016265A1 (ja) | 2001-08-17 | 2004-12-02 | エーザイ株式会社 | 環状化合物およびｐｐａｒアゴニスト |
| US7220877B2 (en) | 2001-10-17 | 2007-05-22 | Novo Nordisk A/S | Compounds, their preparation and use |
| HUP0401837A2 (hu) * | 2001-10-17 | 2004-12-28 | Novo Nordisk A/S | Dikarbonsavszármazékok, előállításuk és gyógyászati alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények |
| ITRM20020014A1 (it) * | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| US7091245B2 (en) | 2002-09-05 | 2006-08-15 | Novo Novdisk A/S | Compounds, their preparation and use |
| EP1745014B1 (en) | 2004-05-05 | 2011-07-06 | High Point Pharmaceuticals, LLC | Novel compounds, their preparation and use |
| US20090042781A1 (en) * | 2004-06-28 | 2009-02-12 | Novo Nordisk A/S | Methods for Treating Diabetes |
| BRPI0620468A2 (pt) | 2005-12-22 | 2011-11-08 | Transtech Pharma Inc | ácidos fenóxi acéticos como ativadores de ppar delta |
| US10307480B2 (en) | 2014-11-06 | 2019-06-04 | Scholar Rock, Inc. | Anti-pro/latent-myostatin antibodies and uses thereof |
| PL3350220T3 (pl) | 2015-09-15 | 2022-01-03 | Scholar Rock, Inc. | Przeciwciała przeciwko pro/latentnej miostatynie i ich zastosowania |
| EP3400240A2 (en) | 2016-01-08 | 2018-11-14 | Scholar Rock, Inc. | Anti-pro/latent myostatin antibodies and methods of use thereof |
| US11155611B2 (en) * | 2017-01-06 | 2021-10-26 | Scholar Rock, Inc. | Compositions and methods for making and using anti-myostatin antibodies |
| BR112023001048A2 (pt) | 2020-07-22 | 2023-04-04 | Reneo Pharmaceuticals Inc | Agonista de ppar-delta cristalino |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2134686C1 (ru) * | 1992-07-03 | 1999-08-20 | Смитклайн Бичам П.Л.С. | Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии |
| FR2707989B1 (fr) * | 1993-07-22 | 1995-10-13 | Pf Medicament | Nouveaux dérivés de benzylamines silylées, leurs sels, leurs procédés de fabrication et les compositions pharmaceutiques les renfermant. |
| BR9508468A (pt) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
| GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
-
2001
- 2001-01-26 JP JP2001555029A patent/JP2003520839A/ja active Pending
- 2001-01-26 KR KR1020027009399A patent/KR20020090211A/ko not_active Application Discontinuation
- 2001-01-26 EP EP01946845A patent/EP1254102A1/en not_active Withdrawn
- 2001-01-26 CN CN01804239A patent/CN1396904A/zh active Pending
- 2001-01-26 WO PCT/DK2001/000057 patent/WO2001055086A1/en not_active Application Discontinuation
- 2001-01-26 MX MXPA02007295A patent/MXPA02007295A/es unknown
- 2001-01-26 PL PL01357017A patent/PL357017A1/xx not_active Application Discontinuation
- 2001-01-26 BR BR0107902-6A patent/BR0107902A/pt not_active IP Right Cessation
- 2001-01-26 HU HU0204247A patent/HUP0204247A3/hu unknown
- 2001-01-26 AU AU28318/01A patent/AU2831801A/en not_active Abandoned
- 2001-01-26 IL IL15025901A patent/IL150259A0/xx unknown
- 2001-01-26 CA CA002396372A patent/CA2396372A1/en not_active Abandoned
-
2002
- 2002-07-26 NO NO20023567A patent/NO20023567L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20023567L (no) | 2002-09-25 |
| WO2001055086A1 (en) | 2001-08-02 |
| MXPA02007295A (es) | 2002-11-29 |
| JP2003520839A (ja) | 2003-07-08 |
| IL150259A0 (en) | 2002-12-01 |
| CN1396904A (zh) | 2003-02-12 |
| BR0107902A (pt) | 2002-11-05 |
| PL357017A1 (en) | 2004-07-12 |
| AU2831801A (en) | 2001-08-07 |
| CA2396372A1 (en) | 2001-08-02 |
| NO20023567D0 (no) | 2002-07-26 |
| EP1254102A1 (en) | 2002-11-06 |
| HUP0204247A2 (hu) | 2003-04-28 |
| KR20020090211A (ko) | 2002-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL150260A0 (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity | |
| AU2002225356A1 (en) | Glucopyranosyloxypyrazole derivatives and use thereof in medicines | |
| MXPA03005923A (es) | Derivados de glupopiranosiloxipirazol y su uso en medicinas. | |
| HUP0201633A3 (en) | Alpha-aminosulphonyl-acetohydroxamic acid derivatives with metalloprotease inhibiting effect, preparation and use thereof | |
| EP1367060A4 (en) | GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE | |
| EP1364957A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE | |
| EP1364958A4 (en) | GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF | |
| IL149374A0 (en) | New use and novel n-azabicyclo-amide derivatives | |
| ZA200410054B (en) | Propionic acid derivatives and their use as hPPARsactivators. | |
| HUP0204247A3 (en) | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity | |
| HUP0302306A3 (en) | Propionic acid derivatives with ppar-alpha activating properties | |
| HUP0201486A2 (en) | Arylmalonic acid dinitrile derivatives, preparation and use thereof | |
| AU2003255463A1 (en) | Substituted isoxazole derivatives and their use in pharmaceutics | |
| GB0023323D0 (en) | Arylhydantoin derivatives and uses thereof | |
| AU2001235437A1 (en) | Isothiazolecarboxylic acid derivatives and their use as microbicides | |
| AU2001261750A1 (en) | Laminate and its use | |
| AU2001286621A1 (en) | Human transporter family members and uses thereof | |
| ZA200204800B (en) | Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity. | |
| AU2002212176A1 (en) | Substituted phenylcyclohexane carboxylic acid amides and the use thereof | |
| ZA200204799B (en) | Propionic acid derivatives and their use in the treatment of diabetes and obesity. | |
| AU5974100A (en) | 6-carboxyphenyldihydropyridazinone derivatives and use thereof | |
| AU2001234180A1 (en) | Benzamide derivative and use thereof | |
| AU2002352281A1 (en) | Device for delivering liquids for human consumption and other uses | |
| AU6150400A (en) | Tetrahydroquinolinyl-6-methyldihydrothiadiazinone derivatives and use thereof | |
| AU2001282268A1 (en) | Phenantridine derivatives and their use as anti-telomerase agent |